Amyris Biotechnologies creates renewable products, focusing on fuels and chemicals. The company is developing renewable fuels that reduce lifecycle (GHG) emissions 80%. The fuel source is special in that it is compatible with current gasoline engines, and can be distributed with existing petroleum infrastructure.

Amyris is also developing semi-synthetic artemisinin, a key ingredient in first-line malaria treatments, in hopes of creating a complementary source of non-seasonal, high-quality, affordable artemisinin. This source would supplement the current botanical supply, offering millions of people infected with malaria the chance to gain consistent and reliable access to lower-cost, life-saving Artemisinin-based Combination Therapies (ACTs). Amyris produces environmentally friendly chemicals for a variety of consumer products and industrial applications currently dependent on petrochemical components.

Company Growth (employees)
Emeryville, US
Size (employees)
440 (est)+6%
Amyris was founded in 2003 and is headquartered in Emeryville, US

Amyris Office Locations

Amyris has an office in Emeryville
Emeryville, US (HQ)
100 5885 Hollis St

Amyris Financials and Metrics

Amyris Financials

Amyris's revenue was reported to be $13 m in Q1, 2017

Revenue (Q1, 2017)

13 m

Gross profit (Q1, 2017)

212 k

Gross profit margin (Q1, 2017), %


Net income (Q1, 2017)

(37.4 m)

EBIT (Q1, 2017)

(27.3 m)

Market capitalization (16-Oct-2017)

76 m

Cash (31-Mar-2017)

1.3 m
Amyris's current market capitalization is $76 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016


41.1 m43.3 m34.2 m67.2 m

Revenue growth, %


Cost of goods sold

38.3 m33.2 m37.4 m56.7 m

Gross profit

2.9 m10.1 m(3.2 m)10.5 m
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017


9.3 m16.3 m7.9 m7.8 m8.6 m8.8 m9.6 m26.5 m13 m

Cost of goods sold

7.5 m10.1 m6.6 m11 m8.5 m11.2 m7.9 m14.9 m12.8 m

Gross profit

1.8 m6.2 m1.2 m(3.1 m)136 k(2.4 m)1.7 m11.7 m212 k

Gross profit Margin, %

USDFY, 2013FY, 2014FY, 2015FY, 2016


6.9 m42 m12 m27.2 m

Accounts Receivable

62.8 k


9.5 m6.5 m5.9 m6.2 m

Current Assets

36.9 m73.6 m35.7 m59.1 m
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017


88.8 m67.2 m43.8 m10.9 m10.9 m7.8 m822 k582 k1.3 m


14.8 m16.7 m11.4 m11.1 m11.1 m7.6 m10 m7.9 m7.1 m

Current Assets

116.8 m102.9 m69.3 m36.1 m34.6 m27.7 m21.5 m21.1 m24.1 m


140.7 m128.1 m104.5 m104 m81.9 m61.8 m65.2 m63.1 m53 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(234.9 m)2.2 m(218.1 m)(97.3 m)

Depreciation and Amortization

16.6 m15 m12.9 m11.4 m

Accounts Receivable

(4.4 m)(1.2 m)4.9 m(9.3 m)

Accounts Payable

(2.6 m)(3.2 m)4.4 m6.4 m
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(35.5 m)(36.7 m)(52.3 m)(47.2 m)(76.7 m)(15.3 m)(13.6 m)(19.7 m)(37.4 m)

Accounts Payable

8.5 m5.8 m4.6 m6.6 m11.3 m7.7 m9.8 m13.8 m16.5 m
USDY, 2017


30.3 k

Financial Leverage

-0.5 x
Show all financial metrics

Amyris Market Value History

Traffic Overview of Amyris

Amyris Online and Social Media Presence

Amyris Company Life and Culture

You may also be interested in